{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:52:06Z","timestamp":1772833926233,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.ymgme.2010.11.162","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T06:00:49Z","timestamp":1291096849000},"page":"368-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Autism associated with low 5-hydroxyindolacetic acid in CSF and the heterozygous SLC6A4 gene Gly56Ala plus 5-HTTLPR L\/L promoter variants"],"prefix":"10.1016","volume":"102","author":[{"given":"Dea","family":"Adamsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Meili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nenad","family":"Blau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beat","family":"Th\u00f6ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Ramaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2010.11.162_bb0005","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(09)61376-3","article-title":"Autism","volume":"374","author":"Levy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00008480-199608000-00008","article-title":"The serotonin system in autism","volume":"8","author":"Cook","year":"1996","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10803-006-0100-7","article-title":"Hyperserotoninemia and altered immunity in autism","volume":"36","author":"Burgess","year":"2006","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9","article-title":"Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children","volume":"45","author":"Chugani","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijdevneu.2004.08.002","article-title":"Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism","volume":"23","author":"Chandana","year":"2005","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/archpsyc.1996.01830110029004","article-title":"Effects of tryptophan depletion in drug-free adults with autistic disorder","volume":"53","author":"McDougle","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4088\/JCP.v67n0311","article-title":"Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability","volume":"67","author":"Kolevzon","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0040","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.neuropharm.2008.08.034","article-title":"How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems","volume":"55","author":"Murphy","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/157015909788848848","article-title":"The serotonergic system: its role in pathogenesis and early developmental treatment of autism","volume":"7","author":"Zafeiriou","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1098\/rstb.2008.0143","article-title":"Enhanced activity of human serotonin transporter variants associated with autism","volume":"364","author":"Prasad","year":"2009","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1096-8628(19980207)81:1<37::AID-AJMG7>3.0.CO;2-K","article-title":"Serotonin transporter (5-HTT) gene and bipolar affective disorder","volume":"81","author":"Esterling","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajmg.b.20158","article-title":"Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits","volume":"127B","author":"Sen","year":"2004","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0065","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/nn1964","article-title":"Long story short: the serotonin transporter in emotion regulation and social cognition","volume":"10","author":"Canli","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2007.12.001","article-title":"Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function","volume":"54","author":"Jennings","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/432648","article-title":"Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors","volume":"77","author":"Sutcliffe","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0080","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(96)90079-3","article-title":"Polymorphism in serotonin transporter gene associated with susceptibility to major depression","volume":"347","author":"Ogilvie","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ridd.2005.03.003","article-title":"Neurochemical correlates of autistic disorder: a review of the literature","volume":"27","author":"Lam","year":"2006","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/mgme.2001.3187","article-title":"A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa","volume":"73","author":"Ramaekers","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0095","unstructured":"J.A. Laros, P.J. Tellegen, Construction and validation of the SON-R 5 1\/2 - 17, the Snijders-Oomen non-verbal intelligence test Thesis (Proefschrift) (1991) Editors: Wolters-Noordhoff. ISBN 90-01-52962-52963. Groningen."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0100","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/clinchem\/47.3.477","article-title":"Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts","volume":"47","author":"Bonafe","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0105","series-title":"Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases","first-page":"89","article-title":"Disorders of phenylalanine and tetrahydrobiopterin metabolism","author":"Blau","year":"2003"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0115","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0006-2952(03)00556-2","article-title":"A unique central tryptophan hydroxylase isoform","volume":"66","author":"Walther","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1471-4159.1999.0720669.x","article-title":"GTP cyclohydrolase I feedback regulatory protein is expressed in serotonin neurons and regulates tetrahydrobiopterin biosynthesis","volume":"72","author":"Kapatos","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0125","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10545-010-9200-9","article-title":"Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders","volume":"33","author":"De Grandis","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1126\/science.1138659","article-title":"Strong association of de novo copy number mutations with autism","volume":"316","author":"Sebat","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10048-009-0171-7","article-title":"Examination of association of genes in the serotonin system to autism","volume":"10","author":"Anderson","year":"2009","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ymgme.2010.11.162_bb0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0079-6123(08)00904-7","article-title":"Functional genetic polymorphisms in serotonin and dopamine gene systems and their significance in behavioural disorders","volume":"172","author":"D'Souza","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0145","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.5356-05.2006","article-title":"Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission","volume":"26","author":"Jennings","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2010.11.162_bb0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/jpn.0427","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J. Psychiatry Neurosci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921000555X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921000555X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:18:38Z","timestamp":1761088718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671921000555X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S109671921000555X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.11.162","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autism associated with low 5-hydroxyindolacetic acid in CSF and the heterozygous SLC6A4 gene Gly56Ala plus 5-HTTLPR L\/L promoter variants","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.11.162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}